Neelam Chhillar

Neelam Chhillar

Auto-generated profile, based on publicly available information

Neelam Chhillar

Deparetment of Biochemistry, School of Medicine, DY Patil University, Navi Mumbai, INDIA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2013 in ISRN Neurology
Verified
Journal Article
Open access
PDF file
NCNeelam Chhillar
Neelam Chhillar
NSNeeraj Kumar Singh
Neeraj Kumar Singh
BBB. D. Banerjee
B. D. Banerjee
KBKiran Bala
Kiran Bala
MMMohammad Mustafa
Mohammad Mustafa
MCMitrabasu Chhillar
Mitrabasu Chhillar
The cause of Parkinson’s disease (PD) remains elusive, but environmental chemical exposures have been postulated to be involved in the etiology of PD. We examined the association between the persistent organochlorine pesticides (OCPs) and PD in the North Indian population. This case control study included 70 PD and 75 control subjects in the age group of 50 to 85 years. Blood samples were collected and high-purity grade hexane and acetone (2 : 1 ratio) were used for extraction of organochlorine residues. OCPs (hexachlorocyclohexane (HCH), aldrin, dieldrin, endosulfan, pp′-Dichlorodiphenyldichloroethylene (pp′-DDE), op′-DDE, pp′- Dichlorodiphenyltrichloroethane (pp′-DDT), op′-DDT, pp′-dichlorodiphenyldichloroethane (pp′-DDD) and op′-DDD) were quantitatively estimated by using gas chromatography. The most frequently detected OCP was dieldrin, which was present in 9.3% of control and 61.4% of PD. The strongest predictor was β-hexachlorocyclohexane (β-HCH), which reported an odds ratio of 2.566, indicating that for every additional one unit of β-HCH, patients had 2.566 times more chances of presence of PD. This study indicates that increased level of β-HCH and dieldrin may be associated with the risk of PD.

15 September 2023 in Current Problems in Cardiology
Verified
Journal Article
Closed access
KRKumar Rajiv
Kumar Rajiv
NCNeelam Chhillar
Neelam Chhillar
Dhruv Sanjay GuptaDhruv Sanjay Gupta
Dhruv Sanjay Gupta
GKGinpreet Kaur
Ginpreet Kaur
SSShailey Singhal
Shailey Singhal
TCTanya Chauhan
Tanya Chauhan

1 November 2017 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RARachna Agarwal
Rachna Agarwal
SCSujata Chaturvedi
Sujata Chaturvedi
NCNeelam Chhillar
Neelam Chhillar
IPIshita Pant
Ishita Pant
ASAnuradha Sharma
Anuradha Sharma
Background: Duchenne muscular dystrophy (DMD), one of the most common X linked muscular disorder, affecting 1 in 3500 male births and is caused by mutation in dystrophin gene. 65% of DMD cases are caused by large deletion of dystrophin gene, followed by duplication (5-10%) or point mutation (25-30%). There is wide mutation spectrum of the mutations in dystrophin gene. Hence, population specific information is needed on mutation spectrum and frequency of common mutations occurring in that particular population for appropriate counseling, prenatal diagnosis and for developing genetic therapy in future. Aims and Objectives: To find out the frequency and distribution of deletion in dystrophin gene in DMD patients along with contribution of pathology and genetic testing in diagnosis of DMD and Becker muscular dystrophy (BMD) in North Indian population.Materials and Methods: Dystrophin gene was screened for deletion by multiplex polymerase chain reaction (PCR). Out of 41 patients, 09 patients underwent muscle biopsy, on which immunohistochemistry was performed for dystrophin, sarcoglycan, dysferlin and merosin.Results: Majority of the deletions were located in distal hotspot region (26/39 ~66.66%) which includes the exons 45-55 and 15.38% of deletions were located at the proximal hotspot region (2- 19 exons).Conclusion: In the present study, 34% patients only showed deletion. Hence complete work up of any muscular dystrophy requires immnohistochemical analysis to see the expression of muscle proteins along with multipleplex PCR test to detect any exon deletion, multiplex ligation-dependent probe amplification (MLPA) to detect point mutation and duplication and western blotting to quantify the dystrophin protein.Asian Journal of Medical Sciences Vol.8(6) 2017 13-18